Astaxanthin supplementation to augment fat oxidation and improve performance in endurance trained athletes

Astaxanthin supplementation to augment fat oxidation and improve performance in endurance trained athletes - Astaxanthin supplementation in cyclist

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36483

Enrollment

Registered

2010-11-12

Start date

2010-12-06

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prestatie en substraatverbruik fatburning time-trial performance

Interventions

astaxanthin (20 mg/day) or placebo for 4 weeks

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Male - Age between 18 and 30 years - Endurance trained (>=3 sessions of endurance exercise per week) - VO2 max >= 50 ml/kg/min - Training history of more than one year of >=3 sessions of endurance exercise per week - BMI

Exclusion criteria

Exclusion criteria: smoking use of medication

Design outcomes

Primary

Measure	Time frame
performance on a time trial after 90 min steady state exercise.	—

Secondary

Measure	Time frame
substrate use plasma glucose plasma lactate plasma free fatty acid plasma astaxanthin plasma troponin	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)